A Single Centric, Randomized, Open Label, Single Arm, Phase III B Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Nutricharge Woman

Abstract This study evaluates the efficacy, safety, and tolerability of Nutricharge WOMAN in improving hemoglobin levels, menstrual health, skin and hair health, and overall quality of life in women of reproductive age. Conducted as a single-center, randomized, open-label, single-arm Phase IIIb clinical trial, the study enrolled 100 female participants between the ages of 12 and 50. Over a 90-day treatment period, subjects were assessed for hemoglobin levels, menstrual health, and quality of life using standardized scales and laboratory tests. Results indicate a significant improvement in hemoglobin levels, menstrual symptoms, skin and hair health, and overall well-being, with minimal adverse effects.